Skip to content
Preprint · OA via OpenAlex

The Funding Channels of Geroscience

Stephanie Lederman

Cold Spring Harbor Perspectives in Medicine · 2022 · ▲ 8 citations

Abstract

This review examines the interconnected channels of government, individual, and corporate funding for geroscience. A sometimes-slow flow of federal and philanthropic funding over 50 years is now becoming sufficient to understand how the processes of aging drive disease. The amount has not yet been enough to push the benefits of geroscience into new therapeutics, but that is poised to change. Prominent billionaires, venture capitalists, and new foundations are investing billions in researching approaches for preventing, delaying, or curing the chronic diseases of older people; major pharmaceutical companies are poised to join them once the Food and Drug Administration qualifies aging as a treatable condition. The coming decade could see considerable progress, not only in the science but also in the creation of fresh nonprofit and for-profit funding streams.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1101/cshperspect.a041210
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Lederman, S. (2022). The Funding Channels of Geroscience. <em>Cold Spring Harbor Perspectives in Medicine</em>. https://doi.org/10.1101/cshperspect.a041210
Vancouver
Lederman S. The Funding Channels of Geroscience. Cold Spring Harbor Perspectives in Medicine. 2022. doi:10.1101/cshperspect.a041210.
BibTeX
@unpublished{stephanie2022TheFun, title = {The Funding Channels of Geroscience}, author = {Stephanie Lederman}, journal = {Cold Spring Harbor Perspectives in Medicine}, year = {2022}, doi = {10.1101/cshperspect.a041210}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings